Loading…
Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro
Summary There have been many reports that high soya-based diets reduce the risk of certain types of cancer. This effect may be due to the presence of high levels of isoflavones derived from the soya bean, particularly genistein which has been shown to be a protein tyrosine kinase (PTK) inhibitor and...
Saved in:
Published in: | British Journal of Cancer 1999-07, Vol.80 (10), p.1550-1557 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c543t-9d7e8e235df28033b2367ec6ac4ad55e26a699bf116464fb718a775d112be5923 |
---|---|
cites | cdi_FETCH-LOGICAL-c543t-9d7e8e235df28033b2367ec6ac4ad55e26a699bf116464fb718a775d112be5923 |
container_end_page | 1557 |
container_issue | 10 |
container_start_page | 1550 |
container_title | British Journal of Cancer |
container_volume | 80 |
creator | Booth, C Hargreaves, D F Hadfield, J A McGown, A T Potten, C S |
description | Summary
There have been many reports that high soya-based diets reduce the risk of certain types of cancer. This effect may be due to the presence of high levels of isoflavones derived from the soya bean, particularly genistein which has been shown to be a protein tyrosine kinase (PTK) inhibitor and have both oestrogenic and anti-oestrogenic properties. We have examined the effect of genistein and a number of novel synthetic analogues on both normal (IEC6, IEC18) and transformed (SW620, HT29) intestinal epithelial cell lines. Responses were compared to those elicited by oestradiol, the anti-oestrogen tamoxifen, and the tyrosine kinase inhibitor tyrphostin. Genistein and tamoxifen were potent inhibitors of cell proliferation. Of seven novel isoflavones tested, none were more potent inhibitors than genistein, and all displayed similar relative activities across the different cell lines. In addition to inhibiting cell proliferation, cell death via apoptosis was observed when the cells were exposed to the isoflavones and all but one exhibited PTK inhibitory activity. These data suggest that by reducing proliferation and inducing apoptosis, possibly due in part to PTK inhibition, isoflavones may have a role in protecting normal intestinal epithelium from tumour development (reducing the risk) and may reduce colonic tumour growth. |
doi_str_mv | 10.1038/sj.bjc.6690559 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2363089</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69892759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c543t-9d7e8e235df28033b2367ec6ac4ad55e26a699bf116464fb718a775d112be5923</originalsourceid><addsrcrecordid>eNp1kc1v1DAQxS1ERZfClRsoB8QtWzuOHfuCVFV8VKrUC1y4WI4z6Try2sF2VuK_x6sspT30NJbeb97M-CH0juAtwVRcpmnbT2bLucSMyRdoQ9qO14wK8hJtMMZdjWWDz9HrlCaMi9ixV-ic4BYLKvkG_bpJYXT6EDykyvqd7W0uNUPK1mtXwWzzDpwtTwPOVXMMzo4QdbbBV9oPBR4WA5Wew5xDskeX6mBzDG_Q2ahdgreneoF-fv3y4_p7fXv37eb66rY2rKW5lkMHAhrKhrERmNK-obwDw7Vp9cAYNFxzKfuREN7yduw7InS5YiCk6YHJhl6gz6vvvPR7GAz4HLVTc7R7Hf-ooK16qni7U_fhoMogioUsBp9OBjH8Xsrlam_T8VrtISxJcSlk07EjuF1BE0NKEcaHIQSrYxwqTarEoU5xlIYPj1d7hK__X4CPJ0Ano90YtTc2_edE10khCna5Yqko_h6imsISSz7p-cnv1w6v8xLhwfGf_he6-7Aa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69892759</pqid></control><display><type>article</type><title>Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro</title><source>Wiley-Blackwell Read & Publish Collection</source><source>PubMed Central</source><creator>Booth, C ; Hargreaves, D F ; Hadfield, J A ; McGown, A T ; Potten, C S</creator><creatorcontrib>Booth, C ; Hargreaves, D F ; Hadfield, J A ; McGown, A T ; Potten, C S</creatorcontrib><description>Summary
There have been many reports that high soya-based diets reduce the risk of certain types of cancer. This effect may be due to the presence of high levels of isoflavones derived from the soya bean, particularly genistein which has been shown to be a protein tyrosine kinase (PTK) inhibitor and have both oestrogenic and anti-oestrogenic properties. We have examined the effect of genistein and a number of novel synthetic analogues on both normal (IEC6, IEC18) and transformed (SW620, HT29) intestinal epithelial cell lines. Responses were compared to those elicited by oestradiol, the anti-oestrogen tamoxifen, and the tyrosine kinase inhibitor tyrphostin. Genistein and tamoxifen were potent inhibitors of cell proliferation. Of seven novel isoflavones tested, none were more potent inhibitors than genistein, and all displayed similar relative activities across the different cell lines. In addition to inhibiting cell proliferation, cell death via apoptosis was observed when the cells were exposed to the isoflavones and all but one exhibited PTK inhibitory activity. These data suggest that by reducing proliferation and inducing apoptosis, possibly due in part to PTK inhibition, isoflavones may have a role in protecting normal intestinal epithelium from tumour development (reducing the risk) and may reduce colonic tumour growth.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1476-5381</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6690559</identifier><identifier>PMID: 10408396</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Animals ; Apoptosis - drug effects ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Cell Division - drug effects ; Colonic Neoplasms - pathology ; Drug Resistance ; Enzyme Inhibitors - pharmacology ; Epidemiology ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Intestinal Mucosa - cytology ; Intestinal Mucosa - drug effects ; Isoflavones - pharmacology ; Leukemia P388 - enzymology ; Leukemia P388 - pathology ; Medical sciences ; Molecular Medicine ; Oncology ; Protein-Tyrosine Kinases - antagonists & inhibitors ; Rats ; Regular ; regular-article ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tamoxifen - pharmacology ; Tumor Cells, Cultured ; Tumors ; Tyrphostins - pharmacology</subject><ispartof>British Journal of Cancer, 1999-07, Vol.80 (10), p.1550-1557</ispartof><rights>The Author(s) 1999</rights><rights>1999 INIST-CNRS</rights><rights>Copyright © 1999 Cancer Research Campaign 1999 Cancer Research Campaign</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c543t-9d7e8e235df28033b2367ec6ac4ad55e26a699bf116464fb718a775d112be5923</citedby><cites>FETCH-LOGICAL-c543t-9d7e8e235df28033b2367ec6ac4ad55e26a699bf116464fb718a775d112be5923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363089/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363089/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1877988$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10408396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Booth, C</creatorcontrib><creatorcontrib>Hargreaves, D F</creatorcontrib><creatorcontrib>Hadfield, J A</creatorcontrib><creatorcontrib>McGown, A T</creatorcontrib><creatorcontrib>Potten, C S</creatorcontrib><title>Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro</title><title>British Journal of Cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Summary
There have been many reports that high soya-based diets reduce the risk of certain types of cancer. This effect may be due to the presence of high levels of isoflavones derived from the soya bean, particularly genistein which has been shown to be a protein tyrosine kinase (PTK) inhibitor and have both oestrogenic and anti-oestrogenic properties. We have examined the effect of genistein and a number of novel synthetic analogues on both normal (IEC6, IEC18) and transformed (SW620, HT29) intestinal epithelial cell lines. Responses were compared to those elicited by oestradiol, the anti-oestrogen tamoxifen, and the tyrosine kinase inhibitor tyrphostin. Genistein and tamoxifen were potent inhibitors of cell proliferation. Of seven novel isoflavones tested, none were more potent inhibitors than genistein, and all displayed similar relative activities across the different cell lines. In addition to inhibiting cell proliferation, cell death via apoptosis was observed when the cells were exposed to the isoflavones and all but one exhibited PTK inhibitory activity. These data suggest that by reducing proliferation and inducing apoptosis, possibly due in part to PTK inhibition, isoflavones may have a role in protecting normal intestinal epithelium from tumour development (reducing the risk) and may reduce colonic tumour growth.</description><subject>Animals</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Cell Division - drug effects</subject><subject>Colonic Neoplasms - pathology</subject><subject>Drug Resistance</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Epidemiology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Intestinal Mucosa - cytology</subject><subject>Intestinal Mucosa - drug effects</subject><subject>Isoflavones - pharmacology</subject><subject>Leukemia P388 - enzymology</subject><subject>Leukemia P388 - pathology</subject><subject>Medical sciences</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Protein-Tyrosine Kinases - antagonists & inhibitors</subject><subject>Rats</subject><subject>Regular</subject><subject>regular-article</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tamoxifen - pharmacology</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Tyrphostins - pharmacology</subject><issn>0007-0920</issn><issn>1476-5381</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNp1kc1v1DAQxS1ERZfClRsoB8QtWzuOHfuCVFV8VKrUC1y4WI4z6Try2sF2VuK_x6sspT30NJbeb97M-CH0juAtwVRcpmnbT2bLucSMyRdoQ9qO14wK8hJtMMZdjWWDz9HrlCaMi9ixV-ic4BYLKvkG_bpJYXT6EDykyvqd7W0uNUPK1mtXwWzzDpwtTwPOVXMMzo4QdbbBV9oPBR4WA5Wew5xDskeX6mBzDG_Q2ahdgreneoF-fv3y4_p7fXv37eb66rY2rKW5lkMHAhrKhrERmNK-obwDw7Vp9cAYNFxzKfuREN7yduw7InS5YiCk6YHJhl6gz6vvvPR7GAz4HLVTc7R7Hf-ooK16qni7U_fhoMogioUsBp9OBjH8Xsrlam_T8VrtISxJcSlk07EjuF1BE0NKEcaHIQSrYxwqTarEoU5xlIYPj1d7hK__X4CPJ0Ano90YtTc2_edE10khCna5Yqko_h6imsISSz7p-cnv1w6v8xLhwfGf_he6-7Aa</recordid><startdate>19990701</startdate><enddate>19990701</enddate><creator>Booth, C</creator><creator>Hargreaves, D F</creator><creator>Hadfield, J A</creator><creator>McGown, A T</creator><creator>Potten, C S</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19990701</creationdate><title>Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro</title><author>Booth, C ; Hargreaves, D F ; Hadfield, J A ; McGown, A T ; Potten, C S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c543t-9d7e8e235df28033b2367ec6ac4ad55e26a699bf116464fb718a775d112be5923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Cell Division - drug effects</topic><topic>Colonic Neoplasms - pathology</topic><topic>Drug Resistance</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Epidemiology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Intestinal Mucosa - cytology</topic><topic>Intestinal Mucosa - drug effects</topic><topic>Isoflavones - pharmacology</topic><topic>Leukemia P388 - enzymology</topic><topic>Leukemia P388 - pathology</topic><topic>Medical sciences</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Protein-Tyrosine Kinases - antagonists & inhibitors</topic><topic>Rats</topic><topic>Regular</topic><topic>regular-article</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tamoxifen - pharmacology</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Tyrphostins - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Booth, C</creatorcontrib><creatorcontrib>Hargreaves, D F</creatorcontrib><creatorcontrib>Hadfield, J A</creatorcontrib><creatorcontrib>McGown, A T</creatorcontrib><creatorcontrib>Potten, C S</creatorcontrib><collection>SpringerOpen</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British Journal of Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Booth, C</au><au>Hargreaves, D F</au><au>Hadfield, J A</au><au>McGown, A T</au><au>Potten, C S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro</atitle><jtitle>British Journal of Cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>1999-07-01</date><risdate>1999</risdate><volume>80</volume><issue>10</issue><spage>1550</spage><epage>1557</epage><pages>1550-1557</pages><issn>0007-0920</issn><eissn>1476-5381</eissn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Summary
There have been many reports that high soya-based diets reduce the risk of certain types of cancer. This effect may be due to the presence of high levels of isoflavones derived from the soya bean, particularly genistein which has been shown to be a protein tyrosine kinase (PTK) inhibitor and have both oestrogenic and anti-oestrogenic properties. We have examined the effect of genistein and a number of novel synthetic analogues on both normal (IEC6, IEC18) and transformed (SW620, HT29) intestinal epithelial cell lines. Responses were compared to those elicited by oestradiol, the anti-oestrogen tamoxifen, and the tyrosine kinase inhibitor tyrphostin. Genistein and tamoxifen were potent inhibitors of cell proliferation. Of seven novel isoflavones tested, none were more potent inhibitors than genistein, and all displayed similar relative activities across the different cell lines. In addition to inhibiting cell proliferation, cell death via apoptosis was observed when the cells were exposed to the isoflavones and all but one exhibited PTK inhibitory activity. These data suggest that by reducing proliferation and inducing apoptosis, possibly due in part to PTK inhibition, isoflavones may have a role in protecting normal intestinal epithelium from tumour development (reducing the risk) and may reduce colonic tumour growth.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>10408396</pmid><doi>10.1038/sj.bjc.6690559</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0920 |
ispartof | British Journal of Cancer, 1999-07, Vol.80 (10), p.1550-1557 |
issn | 0007-0920 1476-5381 1532-1827 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2363089 |
source | Wiley-Blackwell Read & Publish Collection; PubMed Central |
subjects | Animals Apoptosis - drug effects Biological and medical sciences Biomedical and Life Sciences Biomedicine Cancer Research Cell Division - drug effects Colonic Neoplasms - pathology Drug Resistance Enzyme Inhibitors - pharmacology Epidemiology Gastroenterology. Liver. Pancreas. Abdomen Humans Intestinal Mucosa - cytology Intestinal Mucosa - drug effects Isoflavones - pharmacology Leukemia P388 - enzymology Leukemia P388 - pathology Medical sciences Molecular Medicine Oncology Protein-Tyrosine Kinases - antagonists & inhibitors Rats Regular regular-article Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Tamoxifen - pharmacology Tumor Cells, Cultured Tumors Tyrphostins - pharmacology |
title | Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T09%3A03%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Isoflavones%20inhibit%20intestinal%20epithelial%20cell%20proliferation%20and%20induce%20apoptosis%20in%20vitro&rft.jtitle=British%20Journal%20of%20Cancer&rft.au=Booth,%20C&rft.date=1999-07-01&rft.volume=80&rft.issue=10&rft.spage=1550&rft.epage=1557&rft.pages=1550-1557&rft.issn=0007-0920&rft.eissn=1476-5381&rft.coden=BJCAAI&rft_id=info:doi/10.1038/sj.bjc.6690559&rft_dat=%3Cproquest_pubme%3E69892759%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c543t-9d7e8e235df28033b2367ec6ac4ad55e26a699bf116464fb718a775d112be5923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69892759&rft_id=info:pmid/10408396&rfr_iscdi=true |